Contact this trialFirst, we need to learn more about you.
Immunotherapy
ALT-801 for Type 2 Diabetes
Recruiting0 awardsPhase 1
Kansas City, Missouri
This trial is testing a new drug, ALT-801, to see if it is safe and effective in obese people with type 2 diabetes. The trial will compare ALT-801 to a placebo to see if it has any effect on blood sugar levels.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.